日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multimodal Nanoscale Mapping of Local Structure and CO(2) Adsorption in Metal-Organic Frameworks

金属有机框架中局部结构和CO(2)吸附的多模态纳米尺度映射

Karstens, Sarah L; Dods, Matthew N; Saha, Ambarneil; Garai, Máté; Dai, William; Graf, Katerina I; Klein, Ryan A; Jiang, Henry Z H; Cho, Jung; Bustillo, Karen C; Raschke, Markus B; Ercius, Peter; Long, Jeffrey R; Minor, Andrew M

Corrigendum to 'Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer': [ESMO Open. Volume 11, Issue 2, February 2026, 106057]

对“Lazertinib联合立体定向放射治疗寡转移性EGFR突变型非小细胞肺癌”的更正:[ESMO Open. 第11卷,第2期,2026年2月,106057]

Lee, J B; Kim, K H; Yoon, S; Song, S Y; Lee, S S; Jo, S; Ahn, H K; Kim, H J; Choi, S J; Park, H; Hong, M H; Cho, B C; Yoon, H I; Lim, S M

Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer

拉泽替尼联合立体定向放射治疗寡转移性EGFR突变型非小细胞肺癌

Lee, J B; Kim, K H; Yoon, S; Song, S Y; Lee, S S; Jo, S; Ahn, H K; Kim, H J; Choi, S J; Park, H; Hong, M H; Cho, B C; Yoon, H I; Lim, S M

Discovery of 7-(Pyridin-3-yl)thieno[3,2-b]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

发现 7-(吡啶-3-基)噻吩并[3,2-b]吡啶-5-甲酰胺类化合物作为代谢型谷氨酸受体5亚型的负变构调节剂

Henderson, Scott H; Ringuette, Anna E; Whomble, David L; Capstick, Rory A; Richardson, Alexa E; Maurer, Mallory A; Billard, Natasha B; Lei, Xia; Wilkinson, Joshua C; Kethanapalli, Sri H; Cho, Hyekyung P; Rodriguez, Alice L; Niswender, Colleen M; Peng, Weimin; Rook, Jerri M; Chang, Sichen; Blobaum, Anna L; Boutaud, Olivier; Felts, Andrew S; Conn, P Jeffrey; Lindsley, Craig W; Temple, Kayla J

Outcomes and Risk Factors of Widened Difference in Estimated Glomerular Filtration Rate Based on Creatinine or Cystatin C: Adjust Model Development With More Than 300,000 UK Biobank Participants

基于肌酐或胱抑素C估算的肾小球滤过率差异扩大的结局和风险因素:利用超过30万英国生物银行参与者的数据调整模型开发

Kang, Min W; Oh, Jae-Ik; Lee, Jinsun; Kim, Minsang; Koh, Jung H; Cho, Jeong M; Kim, Seong G; Cho, Semin; Lee, Soojin; Kim, Yaerim; Kim, Dong K; Park, Sehoon

Design and implementation of virtual reality-based cognitive training programmes for patients with mild cognitive impairment: Development study

针对轻度认知障碍患者的虚拟现实认知训练方案的设计与实施:开发研究

Choi, Hayeong; Shin, JaeKyoung; Kim, Ji H; Cho, Hyojun; Lee, Sang-Kyu; Ahn, Moo-Eob; Kim, Yeo J

Observation of 1/3 fractional quantum Hall physics in balanced large angle twisted bilayer graphene

在平衡大角度扭曲双层石墨烯中观察到 1/3 分数量子霍尔物理

Kim, Dohun; Jin, Seyoung; Taniguchi, Takashi; Watanabe, Kenji; Smet, Jurgen H; Cho, Gil Young; Kim, Youngwook

AGPAT2 acts at the crossroads of lipid biosynthesis and DRP1-mediated ER morphogenesis.

AGPAT2 在脂质生物合成和 DRP1 介导的内质网形态发生中起着关键作用。

Adachi Yoshihiro, Torres Mauricio, Hunter Allen H, Cho Woo Jung, Pan Meixia, Han Xianlin, Du Guangwei, Qi Ling, Iijima Miho, Sesaki Hiromi

PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients

PALB2种系致病变异:3987例韩国癌症患者中c.3350+5G>A变异的频率、临床特征和功能分析

M-C Kang ,S Lee ,H Kim ,H-S Kang ,S-Y Jung ,J-A Hwang ,J Kwon ,K S Lee ,M C Lim ,S-Y Park ,S H Sim ,W Choi ,J E Park ,E-H Cho ,S-Y Kong

Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)

在一项伞状试验中识别头颈部鳞状细胞癌的预测标志物(KCSG HN 15-16 TRIUMPH 试验)

S Hwang ,M H Hong ,S H Shin ,T Yun ,K-W Lee ,J H Kim ,M J Ahn ,B Keam ,H W Lee ,M K Kim ,H J Yun ,Y Kim ,H J Kim ,S H Cho ,H J An ,S Y Oh ,S-G Park ,Y W Koh ,H K Ahn ,J H Kwon ,Y-G Lee ,K-U Park ,I G Hwang ,S-B Kim ,S Kim ,H R Kim